Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Showing 20 of 0 results

Not applicableStudy completedNCT00067795
What this trial is testing

Evaluating Immune Function Tests in People With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Not applicableStudy completedNCT00001075
What this trial is testing

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT00429845
What this trial is testing

Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial

Who this might be right for
HIV Infections
Hospital de Clinicas de Porto Alegre 80
Testing effectiveness (Phase 2)Study completedNCT00005001
What this trial is testing

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Ended earlyNCT01130376
What this trial is testing

Novel Interventions in HIV-1 Infection

Who this might be right for
HIV-1 Infection
Imperial College London 12
Large-scale testing (Phase 3)Study completedNCT00339456
What this trial is testing

Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 155
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Not applicableStudy completedNCT00272220
What this trial is testing

Longitudinal Study of HAART, Social Networks, & Adherence

Who this might be right for
Acquired Immunodeficiency Syndrome
University of Washington 350
Large-scale testing (Phase 3)Ended earlyNCT00122551
What this trial is testing

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 400
Post-approval studies (Phase 4)Study completedNCT00145795
What this trial is testing

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Who this might be right for
HIV Infections
University of Chicago 20
Not applicableStudy completedNCT01634477
What this trial is testing

Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study

Who this might be right for
HIV InfectionHealthy
Thai Red Cross AIDS Research Centre 816
Not applicableEnded earlyNCT01614405
What this trial is testing

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
University of Alberta 13
Testing effectiveness (Phase 2)Study completedNCT00059462
What this trial is testing

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Who this might be right for
HIV Infections
Bayer 56
Testing effectiveness (Phase 2)Study completedNCT00721305
What this trial is testing

Lovastatin: Immunomodulatory Value Evaluation

Who this might be right for
HIV Seropositivity
Universidad de Antioquia 112
Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Not applicableStudy completedNCT01168167
What this trial is testing

Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

Who this might be right for
HIV-1
Christoph Stephan 20
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Not applicableStudy completedNCT01526421
What this trial is testing

Use of Incentives to Engage Drug Users in HIV Therapy

Who this might be right for
HIV Infection
University of British Columbia 301
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation